United States v. Allan Drug Corp.’s Empirical Analysis
357 F.2d 713 · 1966
Citation profile
28 federal appellate · 5 district · 2 state decisions
How this case has been cited
Cited by 52 later decisions — most recently November 2008 · most notably Public Citizen Health Research Group v. Commissioner, Food & Drug Administration (1984), United States v. Moore (1979)
28 federal appellate · 5 district · 2 state decisions
Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.
Relationships
Relies on United States v. Dotterweich · Atlantic Refining Company v. Federal Trade Commission Goodyear Tire & Rubber Company · Spokane Inland Empire Railroad Company v. United States · Research Laboratories, Inc. v. United States
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 52 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
““the supervisory powers committed to the Secretary [of Health, Education and Welfare under Section 334(d)(1)] undoubtedly carry broad authority to determine whether and in what manner the labeling may be brought within compliance with the act. The judicial function is concerned with the end product of the labeling process. While the final decision lies with the courts, great weight must be given to the. administrative decision.” United States v. Allan Drug Corp., 357 F.2d 713 , 719 (10th Cir. 1966), certiorari denied, 385 U.S. 899 , 87 S.Ct. 203 , 17 L.Ed.2d 131 .”
2 later decisions quote this exact passage“(1) Any drug the composition of which is such that such drug is not generally recognized, among experts qualified by scientific training and experience to evaluate the safety and effectiveness of drugs, as safe and effective for use under the conditions prescribed, recommended, and suggested in the labeling thereof * * * 13”
2 later decisions quote this exact passage“'As to drugs already on the market that have never been subject to the new-drug procedure but are not generally recognized as effective, the burden remains on the Government to prove in court, insofar as unchanged labeling claims are concerned, that they do not have their claimed effect. If the labeling claims are changed, however, these must be approved under the new-drug procedure.”
1 later decision quote this exact passage
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.